403 Recruiting Trials

Clinical Trials for Multiple Sclerosis

MS trials investigate disease-modifying therapies, remyelination strategies, stem-cell transplants, and neuroprotective agents for relapsing and progressive forms of MS.

Showing 15 of 403 recruiting trials

Natural History Study of Progressive Multifocal Leukoencephalopathy (PML)
N/A Bethesda, Maryland +4 more NCT01730131
Recruiting
Application of ihMT MRI in Multiple Sclerosis
NA Marseille, Paca +4 more NCT03600779
Recruiting
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
PHASE2 Birmingham, Alabama +4 more NCT07002034
Recruiting
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
PHASE3 Scottsdale, Arizona +4 more NCT07299019
Recruiting
Delivery of a Culturally Tailored Exercise Training Intervention for Hispanics With Multiple Sclerosis
NA Houston, Texas NCT07606742
Recruiting
A Novel Combinatory Approach to Maximize Functional Recovery of Learning and Memory in Multiple Sclerosis
NA East Hanover, New Jersey +4 more NCT06197685
Recruiting
The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study
NA Atlanta, Georgia +4 more NCT06796504
Recruiting
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
PHASE3 Cullman, Alabama +4 more NCT07325292
Recruiting
Safety and Efficacy of S103 Cells in Progressive/Refractory Multiple Sclerosis
PHASE1 Xi'an, Shaanxi NCT07587125
Recruiting
Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)
N/A Bethesda, Maryland +4 more NCT00001248
Recruiting
Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System
N/A Bethesda, Maryland +4 more NCT00794352
Recruiting
An Open-label Study to Assess the Safety, Efficacy, and Cellular Kinetics of YTB323 in Relapsing Multiple Sclerosis
PHASE1 Darlinghurst, New South Wales +4 more NCT06617793
Recruiting
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
PHASE3 Maitland, Florida +4 more NCT07067463
Recruiting
This Study Involves a Positron Emission Tomography (PET) Scan Using a New Investigational Radioactive Tracer, [18F]-FZTA, to Detect Inflammation in the Brain. The Tracer Will be Tested in Healthy Younger Adults and Individuals With Multiple Sclerosis.
N/A St Louis, Missouri +4 more NCT07115017
Recruiting
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
PHASE1 Birmingham, Alabama +4 more NCT03816345
Recruiting
See all 403 results

Check Your Eligibility

Create a free profile and our AI will match you to trials you may qualify for.

Get Matched — Free
No insurance required
Browse by Condition
Diabetes Cancer Breast Cancer Depression Anxiety Alzheimer's Heart Disease Asthma Multiple Sclerosis Obesity Parkinson's Lupus Hypertension COPD Stroke Arthritis Kidney Disease COVID-19
Browse by State
California Texas New York Florida Illinois Pennsylvania Ohio Georgia North Carolina Michigan New Jersey Washington Arizona Massachusetts Tennessee Colorado Minnesota Maryland Wisconsin Oregon